Pharmaceuticals, Biotechnology and Life Sciences
– Special Meeting of Stockholders Adjourned Until July 12, 2019 BOSTON–(BUSINESS WIRE)–Flex Pharma, Inc. (Nasdaq: FLKS) today announced that approximately…
− On Track to Report ILLUMINATE-A Topline Results in Late 2019 – − In Addition, Company Reports Final Positive Results…
Funding to support regulatory filing and pre-commercial planning for lead product candidate, inebilizumab, and to advance development of additional clinical…
—Proposed acquisition strengthens Pfizer’s innovative biopharmaceutical business and is expected to accelerate its growth trajectory particularly in the long term…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
MAINZ, Germany–(BUSINESS WIRE)–BioNTech SE, a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious…
24-week results demonstrate significant improvement in repigmentation of facial vitiligo lesions after treatment with ruxolitinib cream Data presented at the…
DUBLIN–(BUSINESS WIRE)–The “Global Genitourinary Partnering 2014-2019: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Genitourinary…
DUBLIN–(BUSINESS WIRE)–The “Global Anaphylaxis Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Anaphylaxis Pipeline Highlights…
DUBLIN–(BUSINESS WIRE)–The “Global Ventricular Arrhythmia Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Ventricular Arrhythmia…